Barrow, Hanley, Mewhinney & Strauss
OMCL icon

Barrow, Hanley, Mewhinney & Strauss’s Omnicell OMCL Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.78K Buy
115
+15
+15% +$605 ﹤0.01% 300
2026
Q1 		$3.34K Hold
100
– – ﹤0.01% 297
2025
Q4 		$4.53K Hold
100
– – ﹤0.01% 275
2025
Q3 		$3.04K Buy
100
+14
+16% +$430 ﹤0.01% 298
2025
Q2 		$2.53K Buy
+86
New +$2.57K ﹤0.01% 288

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's OMCL Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss increased its Omnicell (OMCL) stake by 15% in Q2 2026, buying an estimated $605 and bringing the position to 115 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #300.

Barrow, Hanley, Mewhinney & Strauss first reported a position in OMCL in Q2 2025 and has held it in 5 quarters since. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 115 shares of Omnicell worth $4.78K as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss bought 15 Omnicell shares in Q2 2026, an estimated $605.
  • Omnicell made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #300 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Omnicell in Q2 2025 and has held it in 5 quarters since.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.